Helix Biotech is an innovative Contract Development and Manufacturing Organization (CDMO) specializing in the design, development, and production of Lipid Nanoparticles (LNPs), Liposomes, and Hybrid Nanoparticles. We provide nanoparticle manufacturing systems, reagent kits, and off-the-shelf mRNA to accelerate research, manufacturing, and analytics.

Our custom mRNA synthesis services include tailored sequence design, scalable production, and rigorous quality control. We offer formulation, development, and screening for nanoparticles (10–500 nm), including lipids, emulsions, and polymer-based particles, from proof-of-concept to large-scale GMP manufacturing.

Our GMP process development ensures seamless knowledge transfer, while GMP analytical method development covers compendial and customized methods with full validation support. As a contract manufacturer, we deliver sterile production, lot release, aseptic fill/finish, and technology transfer, adhering to 21 CFR Part 210/211 and ICH guidelines.

Helix Biotech is your trusted partner in bringing transformative therapies from concept to clinic.